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ABSTRACT 
Objective
The primary object of this study was to determine the validity of the Australian Type 2 Diabetes Risk Assessment 
Tool (AUSDRISK) for predicting the development of type 2 diabetes in persons with spinal cord injury (SCI). 
Design and setting
The prospective comparative study (December 2013‑March 2014) collected data on AUSDRISK and haemoglobin 
A1c (HbA1c) in participants’ homes. 
Participants
Participation	rate	was	67%	(n=79).	Study	criteria:	over	18	years	of	age,	a	SCI	for	more	than	12	months,	living	at	









Waist circumference and physical activity items require further powered studies to determine if appropriately 
weighted.
Conclusion
Comparing the AUSDRISK with HbA1c assays, the AUSDRISK can predict type 2 diabetes risk in a person with SCI, 
although	further	powered	studies	are	needed	to	be	undertaken,	to	refine	the	predictive	capacity	of	the	tool.





Practitioners 2011). This proportion is escalating. With 275 people being diagnosed with type 2 diabetes 
every day it is anticipated that 3.3 million Australians will be living with the disease by 2031(Vos et al 2004). 
Persons with spinal cord injury (SCI) are at higher risk for type 2 diabetes than the general population, 
primarily due to abnormalities of carbohydrate and lipid metabolism disorders common among persons 
with	SCI	(Raymond	et	al	2010;	Banerjea	et	al	2008;	LaVela	et	al	2006;	Bauman	and	Spungen	2001).	It	has	
been demonstrated that SCI is independently associated with 2‑fold increased odds of type 2 diabetes not 
explained by known risk factors for the disorder (Cragg et al 2015).
Due to adverse changes in body composition, metabolic rate and autonomic function, all known as 




and International Diabetic Federation 2006).
The Australian Type 2 Diabetes Risk Assessment Tool (AUSDRISK), based on nine risk factors was developed 
for	 predicting	 incident	 diabetes	 and	 promoted	 across	 the	 nation	 in	 2008	 (Chen	 et	 al	 2010;	 Australian	
Government	Department	of	Health	and	Ageing	and	Baker	IDI	Heart	and	Diabetes	Institute	2009).	The	survey	
tool provides a simple way to classify adults as low, intermediate or high risk of developing diabetes (Chen 




The AUSDRISK has been validated for the population as a whole (Chen et al 2010), with limited testing in 
population	subgroups	(Fernandez	and	Frost	2013;	Sathish	et	al	2013;	Pasco	et	al	2010).	When	compared	
to multiple other risk assessment methods in a rural Asian population, the AUSDRISK performed equal to 
most other tools in predicting risk of diabetes, dysglycaemia and metabolic syndrome (Sathish et al 2013). 
To date there is no published evidence that the AUSDRISK has been used on persons with SCI to predict 
incident diabetes. Therefore, the primary aim of this study was to determine the validity of the AUSDRISK for 
predicting the development of type 2 diabetes in persons with SCI. 
METHODS
This was a prospective comparative study set in one of Sydney’s metropolitan local health districts. Data 
were collected between December 2013 and March 2014 using convenience sampling. Participants were 
identified	using	a	university	tertiary	hospital	database.	From	the	database	there	were	118	people	identified	
as eligible for the study. Persons were eligible if they were residents of the local health district, older than 
18 years of age, had sustained a SCI for more than 12 months, lived at home, were wheelchair dependent 
and had not been diagnosed with diabetes. All 118 persons were mailed an information sheet and invited 
to contact the lead investigator.
Data were collected at participants’ homes by the principal author. Data included: AUSDRISK screening 
tool, a haemoglobin A1c (HbA1c) assay and an eight item interview tool, based on available literature, was 
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developed by the authors. AUSDRISK items relate to risk factors including: age, gender, ethnicity/country of 
birth, antihypertensive medication usage, smoking, waist measurement, physical activity level, familial history 
of diabetes, fruit and vegetable intake and high blood glucose history. Each answer was scored and the sum 
total	classified	the	participant	as	low	risk	(less	than	5	points),	intermediate	risk	(between	6-11	points)	or	high	
risk	(more	than	12	points)	of	developing	diabetes.	The	interview	tool	questions	included	the	classification	
of the neurological level and severity of the each injury according to the American Spinal Injury Association 
(ASIA) Impairment Scale (AIS) and recorded the individuals’ weight, vital signs, and general practitioner 
contact details. During the home visit, to support health promotion, all participants were offered diabetes 
education and resource material.
To	measure	the	HbA1c,	Point	of	Care	Diagnostics	sponsored	the	loan	blood	analyser	(Afinion	AS100TM). The 
company manager trained the principal author in the use of the equipment. A HbA1c assay was obtained 
using	a	small	capillary	 lancet	finger	prick	of	1.5	µ	which	took	three	minutes	to	analyse.	 Infection	control	
precautions were adhered to throughout the procedure. The point of care analysing device was quality tested 
each	month	(externally)	to	confirm	reliability	and	validity.	For	the	purposes	of	this	study,	a	level	of	HbA1c	6.0%	
was considered the cut‑off point for high risk of the presence of diabetes. 
The	data	were	analysed	using	IBM	SPSS	program	(IBM	SPSS	v.21,	Chicago	IL	USA).	Data	were	summarised	
using frequencies, percentages, means and standard deviations. Associations between continuous score 
and variables and HbA1c were conducted using Pearsons or Spearman’s r correlation and characteristics. 
Associations between categorical variables and HbA1c were conducted using Pearsons Chi‑Square (Χ2) test. 
Receiver	Operating	Characteristics	(ROC)	was	used	to	assess	sensitivity	and	specificity	of	the	AUSDRISK	tool	
and	HbA1c.	Statistical	significance	was	considered	met	at	p=0.05	and	95%	confidence	interval.	
The study was approved by the local Human Research Ethics Committee (HREC 1305‑160M) and operated 
according to the guidelines of the National Health and Medical Research Council of Australia.  
FINDINGS
From the 118 mailed invitations, 24 were ‘returned to sender’, eight persons had diagnosis of diabetes, and 
seven	declined	participation.	The	participation	rate	was	66.9%	(n=79).	Of	the	79	participants,	81%	were	
male and the mean age was 53 years (SD 14.14) (table 1). The mean number of years since injury was 
23.2years	(median	23;	SD	+/-	13.2yrs).	The	most	common	(58%)	neurological	levels	of	SCI	were	within	the	
cervical	region	and	almost	two-thirds	(65.8%)	of	all	the	participants	were	graded	as	AIS	A	(complete	injury).	
The	most	 frequent	 risk	 factors	 identified	were	 insufficient	 exercise	 (58.2%)	 and	 taking	 anti-hypertensive	
medication	(21.5%).	The	average	waist	circumference	was	112.1cm;	with	males	having	an	average	waist	
circumference	of	113.4cm	compared	to	106cm	for	females.	Sixty-four	(81%)	participants	had	the	maximum	
point score available for waist circumference. There was no statistical difference when comparing waist 
measurement with gender (X2 p=.402).
There	was	also	no	difference	in	the	predicted	risk	of	diabetes	or	the	presence	of	diabetes	(HbA1c	%	and	
mmol/mol)	according	to	the	extent	of	the	neurological	deficit	arising	from	the	SCI	(table	2).	
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Table 1:  Participant Characteristics (n = 79)
Characteristic N %











Level of spinal cord injury
Tetraplegia (C3‑8)a 44 55.7
High paraplegia (T1‑T6)b 14 17.7
Low paraplegia (T7‑L2)c 21 26.6
Completeness of spinal cord injury
AISd‑A (Complete) 52 65.8
AIS-B	and	C	(Incomplete) 27 34.1
Risk factors for diabetes
Family history of diabetes 9 11.3
History of hyperglycaemia 7 8.9
Antihypertensive medications 17 21.5
Current smoker 7 8.9
Insufficient	daily	intake	of	fruit	and	vegetables 15 18
Insufficient	exercise	of	<	150	mins/week 46 58.2
Waist circumference (cms, mean, SD) 112.1 19.9
Weight (kgs, mean, SD) 82.5 18.4
a Cervical neurological injury
b Thoracic neurological injury
c Lumbar neurological injury 
d American Spinal Injury Association Impairment Scale: A B C
Table 2: Classification of risk of diabetes (AUSDRISK) for spinal cord injury deficit
Characteristic
Overall Complete
AIS A (n = 52)
Incomplete
AIS B/C (n = 27) P value*
N or mean % or SD N or mean % or SD N or mean % or SD
AUSDRISK score 14.7 5.3 14.67 4.57 14.78 6.59 .93
Low	risk	<5 7 8.9 3 6 4 15 .34
Intermediate
Between	6-11	
19 24 14 27 5 19
High	risk	≥	12 53 67.1 35 67 18 66
HbA1c % 5.3 3.3 5.28 .33 5.39 .35 .16
HbA1c mmol/mol 34.42 3.68 33.98 3.58 35.26 3.80 .14




mol (r = .215, p = .058). 





Table 3. Comparison of HbA1c % and mmol/mol for risk classification (AUSDRISK)
Characteristic
AUSDRISK low/intermediate
< 12 points (n = 26)
AUSDRISK high
≥ 12 points (n = 53) P level*
Mean SD Mean SD
HbA1c % 5.2 .21 5.38 .37 .026




=	 .651;	95%	CI	 .53	 -	 .77)	 (figure	1).	The	 level	of	
HbA1c,	which	had	the	high	risk	classification	with	
the	 highest	 sensitivity	 (.59)	 and	 specificity	 (.73)	
was	5.25%.	
Figure 1: Receiver operating curve for HbA1c percent  
versus high risk classification on AUSDRISK







HbA1c and a high AUSDRISK score.
There	were	limitations	to	this	study.	The	hospital	database	was	reliant	on	all	fields	being	up	to	date.	However,	
addresses	may	have	been	 incorrect	 reducing	 the	potential	 sample	size.	As	a	 result,	 the	study	may	have	
underestimated the number of eligible people residing within the local health district. This was not a powered 
study	and	so	sample	size	limits	the	generalisability.	For	the	purposes	of	this	study,	medical	screening	for	
pre‑existing conditions (e.g. abnormalities of red blood cell structure) known to interfere with HbA1c blood 
analysis	were	not	undertaken,	and	may	have	 influenced	the	findings.	Future	powered	studies	need	to	be	
conducted to determine the validity of the AUSRISK tool for people with SCI. 
Figure 2: Receiver operating curve for HbA1c mmol/
mol versus high riskclassification on AUSDRISK 
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DISCUSSION
The AUSDRISK is a useful screening tool for predicting incident diabetes in the SCI population. The discriminatory 
ability of the AUSRISK was moderate when compared with HbA1c. There was a positive correlation between 
length of time since injury and diabetes risk. Diabetes rates are likely to increase in the SCI population given 
the improvement in life expectancy and anthropometric and physiologic changes associated with ageing with a 
SCI	(Charlifue	et	al	2010;	Banerjea	et	al	2008).	Given	the	strong	association	between	SCI	and	type	2	diabetes	
(Cragg et al 2015), there is an urgent need to monitor diabetes risk factors in this vulnerable patient group. 
The	AUSDRISK	can	provide	a	dual	function	firstly	by	identifying	type	2	diabetes	risk	factors,	while	providing	
an opportunity for health promotion and education. AUSDRISK screening should begin in the acute setting 
and continue in the primary health care setting. Further research needs to explore the screening frequency 





2011) in the normal population. Further powered studies need to be conducted to validate HbA1c sensitivity 
and	specificity	levels	for	persons	with	SCI.
This	study	 identified	that	21.5%	of	participants	were	on	antihypertensive	medication.	Persons	with	a	SCI	
level, which results in high paraplegia or tetraplegia, experience hypotension due to  their blood pressure 
control being impaired, leading to lower resting blood pressures (Middleton et al 2008). This study supports 
the	recent	findings	by	Cragg	et	al	(2015)	that	with	improved	treatment	resulting	in	longevity	that	many	are	





in a SCI population, hence the AUSDRISK has only been validated in populations able to stand for waist 
circumference measurement. However, for persons who are wheel chair dependant and cannot weight bear, 
waist circumference often needs to be measured when seated or in supine position. Therefore, research is 
needed to validate the optimal waist circumference assessment method and scoring system for persons with 
SCI who are wheelchair dependant. 
The	AUSDRISK	also	scores	a	physical	activity	item.	People	need	to	undertake	regular	and	sufficient	exercise	
to	improve	insulin	sensitivity.	It	has	been	identified	that	physical	activity	is	a	greater	determinant	of	glucose	
concentration than neurological lesion level (Raymond et al 2010). For a person with SCI exercising may be 
a	challenge	and	was	reflected	in	the	findings	of	these	results.	The	AUSDRISK	scoring	system	for	physical	
activity needs further validation to determine whether adjusted scores for the SCI population are needed. 
The AUSDRISK also scores ‘ethnicity/country of birth’. This item (Australian born, Aboriginal, Torres Strait 
Islander,	 Pacific	 Islander,	Maori	 descent,	 Asian,	Middle	 Eastern,	North	 African,	 Southern	 European)	may	
need to be further explored to determine what the meaning of ‘Australian born’ is in a multicultural society. 
A	better	definition	of	‘Australian	born’	is	required	to	ensure	that	scores	are	appropriately	weighted	to	identify	
risk in all ethnically diverse sub‑populations. This may be an important factor in determining diabetes risk.
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This study demonstrated that for primary healthcare providers, the use of screening tools and point of care 
testing equipment in the home has the potential to enhance the patient experience, and reduce the burden 
on sub‑groups that are challenged in seeking traditional health care assessments. Further studies need to be 
conducted with portable point of care technologies to improve the detection of preventable diseases within 
the Australian community. 
CONCLUSION
This	study	provides	evidence	that	when	comparing	the	AUSDRISK	risk	classification	to	HbA1c	assay,	the	tool	
can predict incident type 2 diabetes risk in persons with a SCI. The discriminatory ability of the AUSDRISK 
was	moderate	when	compared	with	HbA1c.	Further	powered	studies	are	needed	to	be	undertaken	to	refine	
the predictive capacity of the tool and the frequency rate for screening. Utilising the AUSDRISK could prove 
useful as a screening tool and a health promotional opportunity to monitor and meet the ongoing health 
needs of people with SCI living in the community.  
RECOMMENDATIONS
• AUSDRISK can be used to screen for type 2 diabetes in persons with SCI, although screening frequency 
rate requires further investigation.
• The HbA1c level for predictive risk of diabetes should be lowered in the spinal cord injured population. 
• Further powered studies need to be undertaken to test the AUSDRISK tool to determine predictability 
for wheelchair dependent groups. 
• The scoring for waist circumference and exercise activity items in the AUSDRISK tool require multi‑
centred powered studies to determine weighting for persons with SCI.
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